Drug Profile
Research programme: anti-CD123 monoclonal antibodies - CSL
Alternative Names: 7G3; Monoclonal antibody 7G3Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator CSL
- Class Monoclonal antibodies
- Mechanism of Action Interleukin-3 receptor alpha subunit antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acute myeloid leukaemia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Acute-myeloid-leukaemia in Australia (Parenteral)
- 13 Dec 2007 Preclinical trials in Acute myeloid leukaemia in Australia (Parenteral)